![]() | Form 4 Filings | Insider Buys | Significant Buys | Penny Stocks Insider Buying | Insider Sales |
Insider Buy Sell Ratios | Stock Options | Insider Trading Stock Screener | Insider Trading Graph View | Insider Watch |
| "Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise" - Peter Lynch What is insider trading>> |
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2020-05-26 Sale | 2020-05-28 5:23 pm | Intellia Therapeutics Inc. | NTLA | Rivera Jose E VP | 5,615 | $21.21 | $119,094 | 280,107 (Direct) | View |
2020-06-03 Sale | 2020-06-05 5:18 pm | Intellia Therapeutics Inc. | NTLA | LEONARD JOHN M. CEO | 5,000 | $21.83 | $109,150 | 467,352 (Indirect Direct) | View |
2020-06-16 Sale | 2020-06-18 5:00 pm | Intellia Therapeutics Inc. | NTLA | Rivera Jose E VP | 5,615 | $21 | $117,915 | 22,282 (Indirect Direct) | View |
2020-07-01 Sale | 2020-07-02 4:10 pm | Intellia Therapeutics Inc. | NTLA | LEONARD JOHN M. CEO | 5,000 | $21.83 | $109,150 | 467,352 (Indirect Direct) | View |
2020-07-15 Sale | 2020-07-17 4:18 pm | Intellia Therapeutics Inc. | NTLA | Rivera Jose E VP | 5,615 | $22.7 | $127,461 | 27,524 (Indirect Direct) | View |
2020-08-06 Sale | 2020-08-07 7:29 pm | Intellia Therapeutics Inc. | NTLA | LEONARD JOHN M. CEO | 5,000 | $21.83 | $109,150 | 467,352 (Indirect Direct) | View |
2020-08-18 Sale | 2020-08-20 4:13 pm | Intellia Therapeutics Inc. | NTLA | Rivera Jose E VP | 5,615 | $21 | $117,915 | 31,909 (Indirect Direct) | View |
2020-09-01 Sale | 2020-09-03 4:15 pm | Intellia Therapeutics Inc. | NTLA | LEONARD JOHN M. CEO | 5,000 | $21.83 | $109,150 | 467,352 (Indirect Direct) | View |
2020-09-15 Sale | 2020-09-17 4:55 pm | Intellia Therapeutics Inc. | NTLA | Rivera Jose E VP | 5,615 | $21.04 | $118,140 | 36,294 (Indirect Direct) | View |
2020-10-07 Sale | 2020-10-09 4:14 pm | Intellia Therapeutics Inc. | NTLA | LEONARD JOHN M CEO | 5,000 | $21.83 | $109,150 | 467,352 (Indirect Direct) | View |
2020-10-15 Sale | 2020-10-16 8:58 pm | Intellia Therapeutics Inc. | NTLA | Rivera Jose E VP | 5,615 | $24.2 | $135,883 | 40,679 (Indirect Direct) | View |
2020-11-04 Sale | 2020-11-06 4:38 pm | Intellia Therapeutics Inc. | NTLA | LEONARD JOHN M CEO | 50,000 | $26 | $1,300,000 | 467,352 (Indirect Direct) | View |
2020-11-04 Sale | 2020-11-06 4:41 pm | Intellia Therapeutics Inc. | NTLA | Rivera Jose E VP | 3,364 | $28 | $94,192 | 42,315 (Indirect Direct) | View |
2020-11-16 Sale | 2020-11-18 7:55 pm | Intellia Therapeutics Inc. | NTLA | Rivera Jose E VP | 6,653 | $34.36 | $228,568 | 47,072 (Indirect Direct) | View |
2020-11-16 Sale | 2020-11-18 7:56 pm | Intellia Therapeutics Inc. | NTLA | LEONARD JOHN M CEO | 20,000 | $34 | $680,000 | 467,352 (Indirect Direct) | View |
2020-11-25 Sale | 2020-11-25 8:02 pm | Intellia Therapeutics Inc. | NTLA | LEONARD JOHN M CEO | 50,000 | $36 | $1,800,000 | 467,352 (Indirect Direct) | View |
2020-11-27 Sale | 2020-11-27 9:00 pm | Intellia Therapeutics Inc. | NTLA | LEONARD JOHN M CEO | 35,000 | $38.57 | $1,350,000 | 467,352 (Indirect Direct) | View |
2020-12-01 Sale | 2020-12-03 6:42 pm | Intellia Therapeutics Inc. | NTLA | Rivera Jose E VP | 3,364 | $38.21 | $128,525 | 48,708 (Indirect Direct) | View |
2020-12-17 Sale | 2020-12-18 4:29 pm | Intellia Therapeutics Inc. | NTLA | KARSEN PERRY A Director | 88,764 | $53.55 | $4,753,680 | 5,000 (Direct) | View |
2020-12-31 Sale | 2021-01-05 8:55 pm | Intellia Therapeutics Inc. | NTLA | Rivera Jose E VP | 2,078 | $55.86 | $116,077 | 51,990 (Indirect Direct) | View |
2020-12-31 Sale | 2021-01-05 8:58 pm | Intellia Therapeutics Inc. | NTLA | SCHIERMEIER ANDREW COO | 1,377 | $55.86 | $76,919 | 16,656 (Direct) | View |
2020-12-31 Sale | 2021-01-05 9:24 pm | Intellia Therapeutics Inc. | NTLA | LEONARD JOHN M CEO | 6,239 | $55.86 | $348,511 | 475,488 (Indirect Direct) | View |
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2019-05-21 Option Award | 2019-05-22 4:36 pm | N/A 2029-05-20 | Intellia Therapeutics Inc. | NTLA | Verwiel Frank Director | 19,000 | $15.78 | 19,000 (Direct) | View |
2019-06-03 Option Award | 2019-06-04 4:16 pm | N/A 2029-05-27 | Intellia Therapeutics Inc. | NTLA | Sepp-Lorenzino Laura EVP Chief Scientific Officer | 150,000 | $14.25 | 150,000 (Direct) | View |
2019-08-01 Option Award | 2019-08-02 4:15 pm | N/A 2029-07-31 | Intellia Therapeutics Inc. | NTLA | SCHIERMEIER ANDREW COO | 55,000 | $18.09 | 55,000 (Direct) | View |
2020-01-03 Option Award | 2020-03-04 5:27 pm | 2020-01-03 2027-01-02 | Intellia Therapeutics Inc. | NTLA | SCHIERMEIER ANDREW COO | 15,000 | $13.48 | 135,000 (Direct) | View |
2020-01-03 Option Award | 2020-03-04 5:27 pm | N/A 2030-03-01 | Intellia Therapeutics Inc. | NTLA | SCHIERMEIER ANDREW COO | 135,000 | $13.4 | 135,000 (Direct) | View |
2020-03-02 Option Award | 2020-03-04 5:28 pm | N/A 2030-03-01 | Intellia Therapeutics Inc. | NTLA | Goddard Glenn CFO | 125,000 | $13.4 | 125,000 (Direct) | View |
2020-03-02 Option Award | 2020-03-04 5:28 pm | N/A 2030-03-01 | Intellia Therapeutics Inc. | NTLA | Rivera Jose E VP | 125,000 | $13.4 | 125,000 (Direct) | View |
2020-03-02 Option Award | 2020-03-04 5:30 pm | N/A 2030-03-01 | Intellia Therapeutics Inc. | NTLA | Sepp-Lorenzino Laura EVP Chief Scientific Officer | 135,000 | $13.4 | 135,000 (Direct) | View |
2020-03-02 Option Award | 2020-03-04 5:30 pm | N/A 2030-03-01 | Intellia Therapeutics Inc. | NTLA | LEONARD JOHN M. CEO | 340,000 | $13.4 | 340,000 (Direct) | View |
2020-05-01 Option Award | 2020-05-05 4:49 pm | N/A 2030-04-30 | Intellia Therapeutics Inc. | NTLA | Lebwohl David EVP Chief Medical Officer | 200,000 | $12.62 | 200,000 (Direct) | View |
2020-05-26 Exercise | 2020-05-28 5:23 pm | N/A N/A | Intellia Therapeutics Inc. | NTLA | Rivera Jose E VP | 10,000 | $6.83 | 280,107 (Direct) | View |
2020-05-26 Exercise | 2020-05-28 5:23 pm | N/A 2026-02-02 | Intellia Therapeutics Inc. | NTLA | Rivera Jose E VP | 10,000 | $6.83 | 280,107 (Direct) | View |
2020-06-03 Exercise | 2020-06-05 5:18 pm | N/A N/A | Intellia Therapeutics Inc. | NTLA | LEONARD JOHN M. CEO | 5,000 | $6.83 | 467,352 (Direct) | View |
2020-06-03 Exercise | 2020-06-05 5:18 pm | N/A 2026-02-02 | Intellia Therapeutics Inc. | NTLA | LEONARD JOHN M. CEO | 5,000 | $6.83 | 467,352 (Direct) | View |
2020-06-16 Exercise | 2020-06-18 5:00 pm | N/A N/A | Intellia Therapeutics Inc. | NTLA | Rivera Jose E VP | 10,000 | $6.83 | 22,282 (Direct) | View |
2020-06-16 Exercise | 2020-06-18 5:00 pm | N/A 2026-02-02 | Intellia Therapeutics Inc. | NTLA | Rivera Jose E VP | 10,000 | $6.83 | 22,282 (Direct) | View |
2020-06-18 Option Award | 2020-06-19 4:44 pm | N/A 2030-06-17 | Intellia Therapeutics Inc. | NTLA | DORSA CAROLINE Director | 19,000 | $20.72 | 19,000 (Direct) | View |
2020-06-18 Option Award | 2020-06-19 4:44 pm | N/A 2030-06-17 | Intellia Therapeutics Inc. | NTLA | FORMELA JEAN FRANCOIS Director | 19,000 | $20.72 | 19,000 (Direct) | View |
2020-06-18 Option Award | 2020-06-19 4:45 pm | N/A 2030-06-17 | Intellia Therapeutics Inc. | NTLA | GOODMAN JESSE Director | 19,000 | $20.72 | 19,000 (Direct) | View |
2020-06-18 Option Award | 2020-06-19 4:46 pm | N/A 2030-06-17 | Intellia Therapeutics Inc. | NTLA | KARSEN PERRY A Director | 19,000 | $20.72 | 19,000 (Direct) | View |
2020-06-18 Option Award | 2020-06-19 4:47 pm | N/A 2030-06-17 | Intellia Therapeutics Inc. | NTLA | Verwiel Frank Director | 19,000 | $20.72 | 19,000 (Direct) | View |
2020-06-18 Option Award | 2020-06-19 5:13 pm | N/A 2030-06-17 | Intellia Therapeutics Inc. | NTLA | Cohen Fred E Director | 19,000 | $20.72 | 19,000 (Direct) | View |
2020-07-01 Exercise | 2020-07-02 4:10 pm | N/A N/A | Intellia Therapeutics Inc. | NTLA | LEONARD JOHN M. CEO | 5,000 | $6.83 | 467,352 (Direct) | View |
2020-07-01 Exercise | 2020-07-02 4:10 pm | N/A 2026-02-02 | Intellia Therapeutics Inc. | NTLA | LEONARD JOHN M. CEO | 5,000 | $6.83 | 467,352 (Direct) | View |
2020-07-15 Exercise | 2020-07-17 4:18 pm | N/A N/A | Intellia Therapeutics Inc. | NTLA | Rivera Jose E VP | 10,000 | $6.83 | 27,524 (Direct) | View |
2020-07-15 Exercise | 2020-07-17 4:18 pm | N/A 2026-02-02 | Intellia Therapeutics Inc. | NTLA | Rivera Jose E VP | 10,000 | $6.83 | 27,524 (Direct) | View |
2020-08-06 Exercise | 2020-08-07 7:29 pm | N/A N/A | Intellia Therapeutics Inc. | NTLA | LEONARD JOHN M. CEO | 5,000 | $6.83 | 467,352 (Direct) | View |
2020-08-06 Exercise | 2020-08-07 7:29 pm | N/A 2026-02-02 | Intellia Therapeutics Inc. | NTLA | LEONARD JOHN M. CEO | 5,000 | $6.83 | 467,352 (Direct) | View |
2020-08-18 Exercise | 2020-08-20 4:13 pm | N/A N/A | Intellia Therapeutics Inc. | NTLA | Rivera Jose E VP | 10,000 | $6.83 | 31,909 (Direct) | View |
2020-08-18 Exercise | 2020-08-20 4:13 pm | N/A 2026-02-02 | Intellia Therapeutics Inc. | NTLA | Rivera Jose E VP | 10,000 | $6.83 | 31,909 (Direct) | View |
2020-09-01 Exercise | 2020-09-03 4:15 pm | N/A N/A | Intellia Therapeutics Inc. | NTLA | LEONARD JOHN M. CEO | 5,000 | $6.83 | 467,352 (Direct) | View |
2020-09-01 Exercise | 2020-09-03 4:15 pm | N/A 2026-02-02 | Intellia Therapeutics Inc. | NTLA | LEONARD JOHN M. CEO | 5,000 | $6.83 | 467,352 (Direct) | View |
2020-09-15 Exercise | 2020-09-17 4:55 pm | N/A N/A | Intellia Therapeutics Inc. | NTLA | Rivera Jose E VP | 10,000 | $6.83 | 36,294 (Direct) | View |
2020-09-15 Exercise | 2020-09-17 4:55 pm | N/A 2026-02-02 | Intellia Therapeutics Inc. | NTLA | Rivera Jose E VP | 10,000 | $6.83 | 36,294 (Direct) | View |
2020-10-02 Option Award | 2020-10-05 4:15 pm | N/A 2030-10-01 | Intellia Therapeutics Inc. | NTLA | Crowley John F Director | 38,000 | $18.83 | 38,000 (Direct) | View |
2020-10-07 Exercise | 2020-10-09 4:14 pm | N/A N/A | Intellia Therapeutics Inc. | NTLA | LEONARD JOHN M CEO | 5,000 | $6.83 | 467,352 (Direct) | View |
2020-10-07 Exercise | 2020-10-09 4:14 pm | N/A 2026-02-02 | Intellia Therapeutics Inc. | NTLA | LEONARD JOHN M CEO | 5,000 | $6.83 | 467,352 (Direct) | View |
2020-10-15 Exercise | 2020-10-16 8:58 pm | N/A N/A | Intellia Therapeutics Inc. | NTLA | Rivera Jose E VP | 10,000 | $6.83 | 40,679 (Direct) | View |
2020-10-15 Exercise | 2020-10-16 8:58 pm | N/A 2026-02-02 | Intellia Therapeutics Inc. | NTLA | Rivera Jose E VP | 10,000 | $6.83 | 40,679 (Direct) | View |
2020-11-04 Exercise | 2020-11-06 4:38 pm | N/A N/A | Intellia Therapeutics Inc. | NTLA | LEONARD JOHN M CEO | 50,000 | $6.83 | 467,352 (Direct) | View |
2020-11-04 Exercise | 2020-11-06 4:38 pm | N/A 2026-02-02 | Intellia Therapeutics Inc. | NTLA | LEONARD JOHN M CEO | 50,000 | $6.83 | 467,352 (Direct) | View |
2020-11-04 Exercise | 2020-11-06 4:41 pm | N/A N/A | Intellia Therapeutics Inc. | NTLA | Rivera Jose E VP | 5,000 | $13.88 | 42,315 (Direct) | View |
2020-11-04 Exercise | 2020-11-06 4:41 pm | N/A 2027-01-05 | Intellia Therapeutics Inc. | NTLA | Rivera Jose E VP | 5,000 | $13.88 | 42,315 (Direct) | View |
2020-11-16 Exercise | 2020-11-18 7:55 pm | N/A N/A | Intellia Therapeutics Inc. | NTLA | Rivera Jose E VP | 10,000 | $6.83 | 47,072 (Direct) | View |
2020-11-16 Exercise | 2020-11-18 7:55 pm | N/A N/A | Intellia Therapeutics Inc. | NTLA | Rivera Jose E VP | 562 | $18.3 | 47,072 (Direct) | View |
2020-11-16 Exercise | 2020-11-18 7:55 pm | N/A N/A | Intellia Therapeutics Inc. | NTLA | Rivera Jose E VP | 848 | $18.3 | 47,072 (Direct) | View |
2020-11-16 Exercise | 2020-11-18 7:55 pm | N/A 2026-02-02 | Intellia Therapeutics Inc. | NTLA | Rivera Jose E VP | 10,000 | $6.83 | 47,072 (Direct) | View |
2020-11-16 Exercise | 2020-11-18 7:55 pm | N/A 2027-12-11 | Intellia Therapeutics Inc. | NTLA | Rivera Jose E VP | 562 | $18.3 | 47,072 (Direct) | View |
2020-11-16 Exercise | 2020-11-18 7:55 pm | N/A 2027-12-11 | Intellia Therapeutics Inc. | NTLA | Rivera Jose E VP | 848 | $18.3 | 47,072 (Direct) | View |
2020-11-16 Exercise | 2020-11-18 7:56 pm | N/A N/A | Intellia Therapeutics Inc. | NTLA | LEONARD JOHN M CEO | 20,000 | $14.58 | 467,352 (Direct) | View |
2020-11-16 Exercise | 2020-11-18 7:56 pm | N/A 2028-12-17 | Intellia Therapeutics Inc. | NTLA | LEONARD JOHN M CEO | 20,000 | $14.58 | 467,352 (Direct) | View |
2020-11-25 Exercise | 2020-11-25 8:02 pm | N/A N/A | Intellia Therapeutics Inc. | NTLA | LEONARD JOHN M CEO | 50,000 | $6.83 | 467,352 (Direct) | View |
2020-11-25 Exercise | 2020-11-25 8:02 pm | N/A 2026-02-02 | Intellia Therapeutics Inc. | NTLA | LEONARD JOHN M CEO | 50,000 | $6.83 | 467,352 (Direct) | View |
2020-11-27 Exercise | 2020-11-27 9:00 pm | N/A N/A | Intellia Therapeutics Inc. | NTLA | LEONARD JOHN M CEO | 15,000 | $18.3 | 467,352 (Direct) | View |
2020-11-27 Exercise | 2020-11-27 9:00 pm | N/A N/A | Intellia Therapeutics Inc. | NTLA | LEONARD JOHN M CEO | 20,000 | $14.58 | 467,352 (Direct) | View |
2020-11-27 Exercise | 2020-11-27 9:00 pm | N/A 2027-12-11 | Intellia Therapeutics Inc. | NTLA | LEONARD JOHN M CEO | 15,000 | $18.3 | 467,352 (Direct) | View |
2020-11-27 Exercise | 2020-11-27 9:00 pm | N/A 2028-12-17 | Intellia Therapeutics Inc. | NTLA | LEONARD JOHN M CEO | 20,000 | $14.58 | 467,352 (Direct) | View |
2020-12-01 Exercise | 2020-12-03 6:42 pm | N/A N/A | Intellia Therapeutics Inc. | NTLA | Rivera Jose E VP | 5,000 | $13.88 | 48,708 (Direct) | View |
2020-12-01 Exercise | 2020-12-03 6:42 pm | N/A 2027-01-05 | Intellia Therapeutics Inc. | NTLA | Rivera Jose E VP | 5,000 | $13.88 | 48,708 (Direct) | View |
2020-12-17 Exercise | 2020-12-18 4:29 pm | N/A N/A | Intellia Therapeutics Inc. | NTLA | KARSEN PERRY A Director | 31,764 | $18 | 5,000 (Direct) | View |
2020-12-17 Exercise | 2020-12-18 4:29 pm | N/A N/A | Intellia Therapeutics Inc. | NTLA | KARSEN PERRY A Director | 19,000 | $14.35 | 5,000 (Direct) | View |
2020-12-17 Exercise | 2020-12-18 4:29 pm | N/A N/A | Intellia Therapeutics Inc. | NTLA | KARSEN PERRY A Director | 19,000 | $25.98 | 5,000 (Direct) | View |
2020-12-17 Exercise | 2020-12-18 4:29 pm | N/A N/A | Intellia Therapeutics Inc. | NTLA | KARSEN PERRY A Director | 19,000 | $15.78 | 5,000 (Direct) | View |
2020-12-17 Exercise | 2020-12-18 4:29 pm | N/A 2026-05-04 | Intellia Therapeutics Inc. | NTLA | KARSEN PERRY A Director | 31,764 | $18 | 5,000 (Direct) | View |
2020-12-17 Exercise | 2020-12-18 4:29 pm | N/A 2027-05-17 | Intellia Therapeutics Inc. | NTLA | KARSEN PERRY A Director | 19,000 | $14.35 | 5,000 (Direct) | View |
2020-12-17 Exercise | 2020-12-18 4:29 pm | N/A 2028-05-16 | Intellia Therapeutics Inc. | NTLA | KARSEN PERRY A Director | 19,000 | $25.98 | 5,000 (Direct) | View |
2020-12-17 Exercise | 2020-12-18 4:29 pm | N/A 2029-05-20 | Intellia Therapeutics Inc. | NTLA | KARSEN PERRY A Director | 19,000 | $15.78 | 5,000 (Direct) | View |
2020-12-30 Exercise | 2021-01-04 9:03 pm | N/A N/A | Intellia Therapeutics Inc. | NTLA | SCHIERMEIER ANDREW COO | 1,500 | $13.48 | 148,500 (Direct) | View |
2020-12-30 Exercise | 2021-01-04 9:03 pm | N/A 2027-01-02 | Intellia Therapeutics Inc. | NTLA | SCHIERMEIER ANDREW COO | 1,500 | $13.48 | 148,500 (Direct) | View |
2020-12-31 Exercise | 2021-01-05 8:55 pm | N/A N/A | Intellia Therapeutics Inc. | NTLA | Rivera Jose E VP | 4,792 | $0 | 51,990 (Direct) | View |
2020-12-31 Option Award | 2021-01-05 8:55 pm | 2020-12-31 2028-03-20 | Intellia Therapeutics Inc. | NTLA | Rivera Jose E VP | 9,583 | $23.46 | 51,990 (Direct) | View |
2020-12-31 Option Award | 2021-01-05 8:55 pm | 2020-12-31 N/A | Intellia Therapeutics Inc. | NTLA | Rivera Jose E VP | 4,792 | $0 | 51,990 (Direct) | View |
2020-12-31 Exercise | 2021-01-05 8:55 pm | 2020-12-31 N/A | Intellia Therapeutics Inc. | NTLA | Rivera Jose E VP | 4,792 | $0 | 51,990 (Direct) | View |
2020-12-31 Exercise | 2021-01-05 8:58 pm | N/A N/A | Intellia Therapeutics Inc. | NTLA | SCHIERMEIER ANDREW COO | 4,792 | $0 | 16,656 (Direct) | View |
2020-12-31 Option Award | 2021-01-05 8:58 pm | 2020-12-31 2028-03-20 | Intellia Therapeutics Inc. | NTLA | SCHIERMEIER ANDREW COO | 9,583 | $20.56 | 16,656 (Direct) | View |
2020-12-31 Option Award | 2021-01-05 8:58 pm | 2020-12-31 N/A | Intellia Therapeutics Inc. | NTLA | SCHIERMEIER ANDREW COO | 4,792 | $0 | 16,656 (Direct) | View |
2020-12-31 Exercise | 2021-01-05 8:58 pm | 2020-12-31 N/A | Intellia Therapeutics Inc. | NTLA | SCHIERMEIER ANDREW COO | 4,792 | $0 | 16,656 (Direct) | View |
2020-12-31 Exercise | 2021-01-05 9:24 pm | N/A N/A | Intellia Therapeutics Inc. | NTLA | LEONARD JOHN M CEO | 14,375 | $0 | 475,488 (Direct) | View |
2020-12-31 Option Award | 2021-01-05 9:24 pm | 2020-12-31 2028-03-20 | Intellia Therapeutics Inc. | NTLA | LEONARD JOHN M CEO | 28,750 | $23.46 | 475,488 (Direct) | View |
2020-12-31 Option Award | 2021-01-05 9:24 pm | 2020-12-31 N/A | Intellia Therapeutics Inc. | NTLA | LEONARD JOHN M CEO | 14,375 | $0 | 475,488 (Direct) | View |
2020-12-31 Exercise | 2021-01-05 9:24 pm | 2020-12-31 N/A | Intellia Therapeutics Inc. | NTLA | LEONARD JOHN M CEO | 14,375 | $0 | 475,488 (Direct) | View |
2021-01-20 Exercise | 2021-01-22 4:22 pm | N/A N/A | Intellia Therapeutics Inc. | NTLA | Cohen Fred E Director | 20,000 | $13.78 | 18,000 (Direct) | View |
2021-01-20 Exercise | 2021-01-22 4:22 pm | N/A 2029-01-22 | Intellia Therapeutics Inc. | NTLA | Cohen Fred E Director | 20,000 | $13.78 | 18,000 (Direct) | View |